Neogen vs QuidelOrtho: revenue, profit, margins and growth compared
Neogen brought in $870.4M of revenue in fiscal 2026, QuidelOrtho $2.7B in fiscal 2025. Revenue changed by -2.7% at Neogen and -1.9% at QuidelOrtho on the year before, so QuidelOrtho grew faster. Neogen kept -0.9% of its revenue as net profit, QuidelOrtho -41.5%. Free cash flow was $31.9M at Neogen and -$83M at QuidelOrtho.
Fiscal years as each company reports them; the two may end in different months.
Questions about Neogen and QuidelOrtho
Which is bigger by revenue, Neogen or QuidelOrtho?
QuidelOrtho is bigger by revenue: $2.7B in fiscal 2025, against $870.4M for Neogen in fiscal 2026.
Which keeps more of its revenue as profit, Neogen or QuidelOrtho?
Neogen had a net margin of -0.9% in fiscal 2026; QuidelOrtho had -41.5% in fiscal 2025.
Which grew revenue faster, Neogen or QuidelOrtho?
In their latest fiscal years revenue changed by -2.7% at Neogen and -1.9% at QuidelOrtho.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.